Immune checkpoint inhibitor colitis with concurrent cytomegalovirus reactivation

Intern Med J. 2022 Mar;52(3):504-505. doi: 10.1111/imj.15714.

Authors

Minnie Au¹, Arvind Rajagopalan^{1

2}, Derrick Tee^{1

2}, Hamish Philpott^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Lyell McEwin Hospital, Adelaide, South Australia, Australia.
² Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

PMID: 35307927
DOI: 10.1111/imj.15714

No abstract available

Publication types

Letter

MeSH terms

Colitis* / chemically induced
Colitis* / drug therapy
Cytomegalovirus
Cytomegalovirus Infections* / complications
Cytomegalovirus Infections* / diagnosis
Cytomegalovirus Infections* / drug therapy
Humans
Immune Checkpoint Inhibitors

Substances

Immune Checkpoint Inhibitors